ATE322683T1 - Verfahren zur detektion von antigenspezifischen t-zellen - Google Patents

Verfahren zur detektion von antigenspezifischen t-zellen

Info

Publication number
ATE322683T1
ATE322683T1 AT00923290T AT00923290T ATE322683T1 AT E322683 T1 ATE322683 T1 AT E322683T1 AT 00923290 T AT00923290 T AT 00923290T AT 00923290 T AT00923290 T AT 00923290T AT E322683 T1 ATE322683 T1 AT E322683T1
Authority
AT
Austria
Prior art keywords
mhc
cells
molecules
clusters
complexes
Prior art date
Application number
AT00923290T
Other languages
English (en)
Inventor
Zeling Cai
Michael Jackson
Homero Sepulveda
Jing-Feng Huang
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE322683T1 publication Critical patent/ATE322683T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00923290T 1999-04-16 2000-04-13 Verfahren zur detektion von antigenspezifischen t-zellen ATE322683T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12980599P 1999-04-16 1999-04-16

Publications (1)

Publication Number Publication Date
ATE322683T1 true ATE322683T1 (de) 2006-04-15

Family

ID=22441679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00923290T ATE322683T1 (de) 1999-04-16 2000-04-13 Verfahren zur detektion von antigenspezifischen t-zellen

Country Status (13)

Country Link
US (2) US20020049302A1 (de)
EP (1) EP1179176B1 (de)
JP (1) JP4673978B2 (de)
AT (1) ATE322683T1 (de)
AU (1) AU763757B2 (de)
CA (1) CA2370557C (de)
CY (1) CY1105064T1 (de)
DE (1) DE60027152T2 (de)
DK (1) DK1179176T3 (de)
ES (1) ES2261197T3 (de)
HK (1) HK1041312B (de)
PT (1) PT1179176E (de)
WO (1) WO2000063690A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2306771T3 (es) * 2001-02-20 2008-11-16 Ortho Mcneil Pharm Inc Un metodo de terapia celular para tratamiento de tumores.
US20040071671A1 (en) * 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
WO2004084838A2 (en) * 2003-03-24 2004-10-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification, quantification, and characterization of t cells and t cell antigens
GB0502065D0 (en) * 2005-02-01 2005-03-09 Queen Mary & Westfield College Assay method
CN101548008B (zh) 2006-10-04 2013-04-17 詹森药业有限公司 失活的人工抗原提呈细胞的制备及其在细胞疗法中的用途
EP2155782A2 (de) 2007-03-26 2010-02-24 Dako Denmark A/S Mhc-peptid-komplexe und anwendungen davon bei infektionskrankheiten
WO2009003493A2 (en) 2007-07-03 2009-01-08 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
WO2010009735A2 (en) * 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2020127222A2 (en) 2018-12-17 2020-06-25 Immudex Aps Panel comprising borrelia mhc multimers
US20230241105A1 (en) * 2020-06-11 2023-08-03 La Jolla Institute For Immunology Methods of use of allergen-specific t cells in allergy and asthma
KR102751115B1 (ko) * 2020-10-20 2025-01-09 연세대학교 산학협력단 단일 세포 분석법을 이용한 tcr-항원의 특이성을 확인하는 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
US5734023A (en) * 1991-11-19 1998-03-31 Anergen Inc. MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
US5583031A (en) * 1992-02-06 1996-12-10 President And Fellows Of Harvard College Empty major histocompatibility class II heterodimers
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
CN1112933A (zh) * 1994-01-20 1995-12-06 伯伦格·曼海姆有限公司 抗原特异性活化t淋巴细胞，其检测和用途
US5820866A (en) * 1994-03-04 1998-10-13 National Jewish Center For Immunology And Respiratory Medicine Product and process for T cell regulation
US5595881A (en) * 1994-08-09 1997-01-21 Anergen, Inc. Method for the detection of antigen presenting cells
US5858777A (en) * 1995-09-08 1999-01-12 Geron Corporation Methods and reagents for regulating telomere length and telomerase activity
US5869270A (en) * 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
ES2277358T3 (es) * 1996-09-06 2007-07-01 Ortho-Mcneil Pharmaceutical, Inc. Purificacion de celulas t especificas de antigeno.
GB9718745D0 (en) * 1996-12-03 1997-11-12 Medical Res Council Improvements in or relating to screening for carcinoma
US6245564B1 (en) * 1997-01-23 2001-06-12 Cornell Research Foundation, Inc. Method for separating cells
AU741130B2 (en) * 1997-09-16 2001-11-22 Oregon Health Sciences University Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
US6790662B1 (en) * 1999-03-12 2004-09-14 Ortho-Mcneil Pharmaceutical, Inc. Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptides

Also Published As

Publication number Publication date
AU763757B2 (en) 2003-07-31
EP1179176A4 (de) 2002-09-25
DE60027152T2 (de) 2007-01-04
US20020049302A1 (en) 2002-04-25
DE60027152D1 (de) 2006-05-18
PT1179176E (pt) 2006-07-31
CA2370557C (en) 2007-12-04
CY1105064T1 (el) 2009-11-04
HK1041312A1 (en) 2002-07-05
US20060234310A1 (en) 2006-10-19
AU4344300A (en) 2000-11-02
WO2000063690A1 (en) 2000-10-26
HK1041312B (en) 2006-09-29
JP2002542483A (ja) 2002-12-10
EP1179176A1 (de) 2002-02-13
CA2370557A1 (en) 2000-10-26
DK1179176T3 (da) 2006-08-07
ES2261197T3 (es) 2006-11-16
JP4673978B2 (ja) 2011-04-20
EP1179176B1 (de) 2006-04-05

Similar Documents

Publication Publication Date Title
DE60027152D1 (de) Verfahren zur detektion von antigenspezifischen t-zellen
ES2112559T3 (es) Induccion de respuesta de anticuerpos contra proteinas endogenas con ayuda de epitopes de celulas t extrañas.
Baker et al. Identification and removal of immunogenicity in therapeutic proteins
ATE411522T1 (de) Hochaffine t-zellrezeptorproteine und verfahren
DE69721293D1 (de) Einrichtung zur verabreichung von substanzen wie lidocain und epinephrin mit unterstuetzung von elektrischem strom
EA200300815A1 (ru) Способ клеточной терапии для лечения опухолей
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
WO2002010350A1 (en) Method of proliferating natural killer cells
FR2812087B1 (fr) Procede de criblage de peptides utilisables en immunotherapie
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
van den Berg et al. Intradermal vaccination by DNA tattooing
Joncker et al. Antigen‐independent accumulation of activated effector/memory T lymphocytes into human and murine tumors
DE69821506D1 (de) Verwendung einer chemisch stabilisierten chloritlösung zur inhibition der antigenspezifischen immunantwort
CY1107952T1 (el) Δενδριτικα κυτταρα ενεργοποιημενα εν τη παρουσια γλυκοκορτικοειδων ορμονων ειναι ικανα να καταστελλουν αντιγονο-ειδικες αποκρισεις κυτταρων
Bygrave et al. Btbd11 is an inhibitory interneuron specific synaptic scaffolding protein that supports excitatory synapse structure and function
Huang et al. Orofacial inflammatory pain affects the expression of MT1 and NADPH-d in rat caudal spinal trigeminal nucleus and trigeminal ganglion
ES2132027B1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
Biswas et al. Culture‐differentiated CD8+ T cells acquire innate memory‐like traits and respond to a pathogen‐associated molecule
Soria et al. Long‐term maintenance of skin immune system in a NOD‐Scid IL 2rγnull mouse model transplanted with human skin
Cai et al. Investigation of Cysteine Modifications in Recombinant Protein Tetanus Toxoid Heavy Chain Fragment C
Lein Differentiation of AHPC Neurospheres on Gold Substrates undergoing Electric Stimulation
Kina et al. Concanavalin A-mediated polyclonal helper assay of normal thymocytes and its use for the analysis of ontogeny
Stanovnik et al. Mast cell histamine in gastric secretion—a study on the isolated portion of a guinea pig stomach
Blumenthal et al. Nonreplicating cultures of frog gastric tubular cells
KRØLL ON THE RECOGNITION OF TUMOR ASSOCIATED ANTIGENS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1179176

Country of ref document: EP